SCHEMBL4299632

SCHEMBL4299632

COc1cc(C=CCO)cc(OC)c1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP1B1 Q16678 1/20 0.58
GAA P10253 1/20 0.58
HTT P42858 1/20 0.58
KDM4E B2RXH2 1/20 0.58
ALDH1A1 P00352 1/20 0.58
HTR1A P08908 1/20 0.58
HPGD P15428 1/20 0.58
HTR2C P28335 1/20 0.58
HSD17B10 Q99714 1/20 0.58
MAPT P10636 1/20 0.57
TUBB1 Q9H4B7 12/20 0.56
TUBB4A P04350 7/20 0.56
TUBB P07437 7/20 0.56
TUBA3C P0DPH7 7/20 0.56
TUBA1B P68363 7/20 0.56
TUBA4A P68366 7/20 0.56
TUBB4B P68371 7/20 0.56
TUBB3 Q13509 7/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004805 1.00 CYP1A1 (0.58) CYP1A1CYP1A2CYP1B1GAAHTT
SCHEMBL30887916 1.00 CYP1A1 (0.58) CYP1A1CYP1A2CYP1B1GAAHTT
SCHEMBL20376311 0.89 TUBB1 (0.54) CYP1A1CYP1A2CYP1B1GAAHTT
SCHEMBL9763615 0.87 TUBB1 (0.55) CYP1A1CYP1A2CYP1B1GAAHTT
SCHEMBL9763608 0.87 TUBB1 (0.55) CYP1A1CYP1A2CYP1B1GAAHTT
SCHEMBL14007277 0.86 MAPT (0.49) CYP1A1CYP1A2CYP1B1GAAHTT
SCHEMBL1457517 0.86 ABL1 (0.59) CYP1A2GAAHTTKDM4EHPGD
SCHEMBL807443 0.86 ABL1 (0.59) CYP1A2GAAHTTKDM4EHPGD
SCHEMBL29603846 0.86 ABL1 (0.59) CYP1A2GAAHTTKDM4EHPGD
SCHEMBL12963108 0.84 TUBB1 (0.59) CYP1A1CYP1A2CYP1B1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115611840-B Cold winter honey element and preparation method and application thereof 广西梧州甜蜜家蜂业有限公司 2024-03-26 CN claimed
CN-101448395-A Compositions and methods for increasing the value of plant products, enhancing their commercial quality, enhancing their resistance to external agents and increasing their polyphenol content ANTONI LESCHOT SANHUEZA ANDRES (CL) 2009-06-03 CN claimed
EP-2003968-A2 COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PRODUCTS, SO INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF Leschot Sanhueza, Andres Antonio (CL) 2008-12-24 EP claimed
US-20070232495-A1 Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof NAPPA ALVARO O 2007-10-04 US claimed
WO-2007110801-A2 COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PORDUCTS, INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF LESCHOT SANHUEZA ANDRES ANTONI (CL) 2007-10-04 WO claimed
CN-115611840-B Cold winter honey element and preparation method and application thereof 广西梧州甜蜜家蜂业有限公司 2024-03-26 CN disclosed
EP-1927889-B1 Lithographic printing plate precursor FUJIFILM CORP (JP) 2014-06-25 EP disclosed
CN-101448395-A Compositions and methods for increasing the value of plant products, enhancing their commercial quality, enhancing their resistance to external agents and increasing their polyphenol content ANTONI LESCHOT SANHUEZA ANDRES (CL) 2009-06-03 CN disclosed
US-20090043109-A1 ASYMMETRIC ONE- AND TWO-PHOTON FLUOROPHORES FOR SIMULTANEOUS DETECTION OF MULTIPLE ANALYTES USING A COMMON EXCITATION SOURCE SENSOPATH TECHNOLOGIES, INC. 2009-02-12 US disclosed
EP-2003968-A2 COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PRODUCTS, SO INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF Leschot Sanhueza, Andres Antonio (CL) 2008-12-24 EP disclosed
EP-1927889-A1 Lithographic printing plate precursor FUJIFILM Corporation (JP) 2008-06-04 EP disclosed
EP-1400513-B1 UNSYMMETRICAL CYCLIC DIAMINE COMPOUND KOWA CO (JP) 2008-01-09 EP disclosed
US-5089513-A Antiinflammatory agents; antiallergens; asthma; side effect reduction ICI PHARMA (FR) 1992-02-18 US disclosed
US-5089639-A N-CYCLOALKYLALKYLAMINES, PROCESS FOR THEIR PREPARATION, THEIR USE AS A MEDICAMENT AND THEIR SYNTHESIS INTERMEDIATES JOUVEINAL S.A. (FR) 1992-02-18 US disclosed
US-5034419-A Psychological disorders or gastrointestinal disorders L'OREAL (FR) 1991-07-23 US disclosed
EP-0351194-A2 Thiazole derivatives having a 5-lipoxygenase-inhibiting activity IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-01-17 EP disclosed
US-4704462-A PLATELET-ACTIVATING FACTOR MERCK & CO., INC. (US) 1987-11-03 US disclosed
US-4687727-A Light-sensitive planographic printing plate with layer of diazo resin containing photopolymerizable composition FUJI PHOTO FILM CO., LTD. (JP) 1987-08-18 US disclosed
US-4511645-A ALLYL METHACRYLATE-METHACRYLIC ACID COPOLYMER, CURING AGENT, PHOTOINITIATOR FUJI PHOTO FILM CO., LTD. (JP) 1985-04-16 US disclosed
EP-0104863-A2 Light-sensitive planographic printing plate FUJI PHOTO FILM CO., LTD. (JP) 1984-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232495-A1 Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof C5, PNN, NQO1 CYP1A1 444/4885CYP1A2 966/4885CYP1B1 904/4885
US-20090043109-A1 ASYMMETRIC ONE- AND TWO-PHOTON FLUOROPHORES FOR SIMULTANEOUS DETECTION OF MULTIPLE ANALYTES USING A COMMON EXCITATION SOURCE ALDH1B1, ALDH2, ALDH3A1 CYP1A1 1058/4885CYP1A2 2117/4885CYP1B1 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.